ClinConnect ClinConnect Logo
Search / Trial NCT06530602

3-Dimensional Shoulder Complex Pain Alignment (3-D SPA) Mobilization on Frozen Shoulder.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 28, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Frozen Shoulder Qol Clinical Trail 3 D Spa Spadi

ClinConnect Summary

This clinical trial is studying a new treatment approach for people with frozen shoulder, a condition that causes stiffness and pain in the shoulder joint, making it hard to move the arm. Researchers want to see if a special technique called 3-Dimensional Shoulder Pain Alignment (3-D SPA) mobilization, combined with regular therapy, can help improve shoulder movement and reduce pain more effectively than standard shoulder mobilization alone. A total of 36 participants will be involved in the study, which is currently looking for volunteers.

To be eligible for the trial, participants should have noticeable shoulder pain and significant limitations in shoulder movement, especially in turning the arm outward. They should also not have certain conditions, like nerve issues or recent shoulder injections. Those who join the study can expect to receive either the new mobilization technique or standard therapy over the course of the trial. It’s a chance to potentially improve their shoulder function and quality of life while contributing to important research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Local shoulder pain, often present either above the antero-medial and Lateral aspect of the shoulder.
  • Stage II\& III unilateral frozen shoulder Symptoms.
  • Marked loss Of AROM \& PROM with at least 50%loss of external rotation.
  • Positive Apley's Scratch test.
  • Exclusion Criteria:
  • Radiculopathy.
  • Thoracic-outlet syndrome.
  • Fractures and tumors of the upper extremity.
  • Neurological disorders causing muscle weakness in the shoulder.
  • Corticosteroid injection for frozen shoulder in last 3 months.

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Rawalpindi, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Madiha Ali, MSOMPT

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported